“…In vitro studies showed that this molecule may regulate cell differentiation and proliferation and exhibits growth-inhibiting effects against several human cancer cell lines including HL-60 and HL60/MX2 promyelocytic leukemia, U937 histiocytic lymphoma, MCF-7, T47D human breast cancer, HT-29 human colon cancer, and human SCC (Colston et al, 1992;Meephansan et al, 2012;Milczarek et al, 2013aMilczarek et al, , 2014. Regarding the possible mechanisms underlying the growth inhibiting and pro-differentiating effects of calcipotriol on tumor cells, in vitro studies highlighted the fact that a 20-h exposure of LNCaP prostate cancer cells and MCF-7 breast cancer cells to this analogue or to BGP-15, a new calcipotriene-derived vitamin D 3 analogue, generated procaspase-3 cleavage and ultimately, apoptosis (Berkovic et al, 2010). In addition, Wang et al (2010b) recently reported that calcipotriol significantly suppressed in vitro colon carcinoma cell invasion and enhanced the cytotoxicity of the anticancer regimen FOLFIRI (folinic acid, 5-FU, irinotecan) to cells in culture or in anchorage-independent growth.…”